Filing Details

Accession Number:
0001127602-20-018892
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-06-04 18:33:04
Reporting Period:
2020-05-15
Accepted Time:
2020-06-04 18:33:04
Original Submission Date:
2020-05-19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682852 Moderna Inc. MRNA () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1643746 H. Lorence Kim C/O Moderna, Inc.
200 Technology Square
Cambridge MA 02139
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-15 2,600 $63.80 1,219,910 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 28, 2018, as amended on September 18, 2019.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.27 to $64.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.